To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

111In-DTPA-D-Phe1-octreot… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.

Journal article
Authors Eva Forssell-Aronsson
Ola Nilsson
S A Bejegård
Lars Kölby
Peter Bernhardt
Johan Mölne
S H Hashemi
Bo Wängberg
Lars-Eric Tisell
Håkan Ahlman
Published in Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Volume 41
Issue 4
Pages 636-42
ISSN 0161-5505
Publication year 2000
Published at Institute of Selected Clinical Sciences, Department of Radiation Physics
Institute of Laboratory Medicine, Dept of Pathology
Institute of Surgical Sciences, Department of Surgery
Pages 636-42
Language en
Keywords Blotting, Northern, Humans, Indium Radioisotopes, diagnostic use, therapeutic use, Lymphatic Metastasis, Octreotide, analogs & derivatives, diagnostic use, pharmacokinetics, therapeutic use, Pentetic Acid, analogs & derivatives, diagnostic use, pharmacokinetics, therapeutic use, RNA, Messenger, genetics, Radiopharmaceuticals, diagnostic use, therapeutic use, Receptors, Somatostatin, classification, metabolism, Thyroid Gland, metabolism, Thyroid Neoplasms, metabolism, radiotherapy
Subject categories Cancer and Oncology


The purpose of this study was to evaluate the potential for therapy of thyroid tumors using the radiolabeled somatostatin (SS) analog octreotide.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?